The addition of the chemical melamine to Chinese dairy products has caused more than 10 infant deaths worldwide and over 50,000 children in China to be hospitalized. Melamine in itself is not harmful, but when levels are high enough, it can cause crystals to form in the liver, leading to renal failure. This scandal comes […]
A total of 633 biotechnology medicines for more than 100 diseases are currently in development, according to the Pharmaceutical Research and Manufacturers of America (PhRMA). By therapeutic category, with some medicines counted in more than one category, the number of biotech medicines in development for cancer and related conditions, at 254, and infectious disease, at […]
A recent report prepared by the US Government Accountability Office (GAO) found that the FDA’s monitoring of fresh produce is deficient. In fiscal 2007, the FDA spent a minimum of $20.2 million, approximately 3% of its food safety expenditures, on fresh produce oversight. The FDA’s Office of Regulatory Affairs accounted for 82% of this spending, […]
According to Hydrocarbon Processing’s HPI Construction Boxscore Survey, the total number of hydrocarbon projects worldwide grew 12% between June 2007 and June 2008 to 5,029. Rising the fastest were the number of synfuel projects, which grew 15%, while gas processing projects increased 15% and refining projects rose 11%. All other projects grew 26%. However, the […]
This month, the FDA issued draft guidance on regulating genetically engineered animals (GE) for a 60-day comment period. A GE animal contains a heritable recombinant DNA (rDNA) construct that gives it new traits or characteristics. GE animals include animals that produce pharmaceuticals, industrial or consumer products, as well as animals used as human disease models […]
Point-of-care testing (POCT) is contributing to the growth of the diagnostics product market. In the first six months of this year, the FDA approved 152 POC tests. InteLab estimates that POCT represented 35% of the in vitro diagnostics market in 2005 and that, by 2011, it will account for 41%. In 2005, the market for […]
New rules for labeling fresh produce and meat by country of origin went into effect in the US on September 30. Manufactures have six months to comply with the rules. However, loopholes in the law exempt processed foods and mixed vegetables. In addition, labels on meat cuts can show more than one country of origin. […]
An investigation by the Associated Press (AP) has drawn attention to the dumping of unused pharmaceuticals by the US’s 5,700 hospitals and 45,000 nursing homes. Based on records from 14 hospitals in Minnesota, the AP estimated that a minimum of 250 million pounds of drug waste are disposed of annually through sewer systems. Other sources […]
The Broad Institute of Harvard and MIT received a $400 million endowment from Eli and Edythe L. Broad to permanently establish the Institute as a nonprofit organization. Founded in 2004, the Institute was initially created as a venture experiment with $100 million in funding from the Broads, who donated an additional $100 million in 2005. […]
In September, scientists from the Europe, Japan and the US announced the formation of the International Alliance for NanoEHS Harmonization (IANH). Using round robin experiments, the IANH will develop standard protocols for the toxicological testing of nanomaterials at the cell and animal levels. The protocols will be used for hazard assessment and to rank the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
